Kilitch Drugs (India) Limited (KILITCH) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.025x

Based on the latest financial reports, Kilitch Drugs (India) Limited (KILITCH) has a cash flow conversion efficiency ratio of -0.025x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-66.20 Million ≈ $-715.95K USD) by net assets (Rs2.64 Billion ≈ $28.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Kilitch Drugs (India) Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Kilitch Drugs (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Kilitch Drugs (India) Limited total liabilities for a breakdown of total debt and financial obligations.

Kilitch Drugs (India) Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kilitch Drugs (India) Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Nice D&B Co. Ltd KQ:130580	0.023x
Montebalito S.A. MC:MTB	0.012x
Changhong Meiling Co Ltd B SHE:200521	0.403x
DocCheck AG XETRA:AJ91	0.112x
Studio Mir Co. Ltd. KQ:408900	-0.078x
Microcosm Technology Co Ltd TWO:3354	-0.025x
Doxa AB ST:DOXA	0.055x
Moberg Pharma AB (publ) ST:MOB	-0.012x

Annual Cash Flow Conversion Efficiency for Kilitch Drugs (India) Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Kilitch Drugs (India) Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Kilitch Drugs (India) Limited market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs2.00 Billion ≈ $21.68 Million	Rs175.42 Million ≈ $1.90 Million	0.088x	+10608.11%
2024-03-31	Rs1.76 Billion ≈ $19.00 Million	Rs-1.46 Million ≈ $-15.82K	-0.001x	-104.85%
2023-03-31	Rs1.51 Billion ≈ $16.28 Million	Rs25.86 Million ≈ $279.64K	0.017x	-58.34%
2022-03-31	Rs1.40 Billion ≈ $15.17 Million	Rs57.83 Million ≈ $625.41K	0.041x	-88.31%
2021-03-31	Rs1.29 Billion ≈ $14.00 Million	Rs456.59 Million ≈ $4.94 Million	0.353x	+1034.35%
2020-03-31	Rs1.20 Billion ≈ $13.03 Million	Rs37.45 Million ≈ $405.02K	0.031x	+1216.09%
2019-03-31	Rs1.23 Billion ≈ $13.32 Million	Rs2.91 Million ≈ $31.46K	0.002x	-81.28%
2018-03-31	Rs1.13 Billion ≈ $12.19 Million	Rs14.23 Million ≈ $153.90K	0.013x	+13.89%
2017-03-31	Rs1.01 Billion ≈ $10.94 Million	Rs11.21 Million ≈ $121.28K	0.011x	-93.01%
2016-03-31	Rs1.09 Billion ≈ $11.75 Million	Rs172.33 Million ≈ $1.86 Million	0.159x	+349.49%
2015-03-31	Rs1.20 Billion ≈ $12.96 Million	Rs-76.18 Million ≈ $-823.90K	-0.064x	+75.42%
2014-03-31	Rs1.20 Billion ≈ $13.00 Million	Rs-310.84 Million ≈ $-3.36 Million	-0.259x	-2155.68%
2013-03-31	Rs1.19 Billion ≈ $12.88 Million	Rs14.97 Million ≈ $161.93K	0.013x	+104.95%
2012-03-31	Rs1.16 Billion ≈ $12.50 Million	Rs-293.49 Million ≈ $-3.17 Million	-0.254x	-217.16%
2011-03-31	Rs858.72 Million ≈ $9.29 Million	Rs186.05 Million ≈ $2.01 Million	0.217x	+3.92%
2010-03-31	Rs740.88 Million ≈ $8.01 Million	Rs154.46 Million ≈ $1.67 Million	0.208x	+27.83%
2009-03-31	Rs643.97 Million ≈ $6.96 Million	Rs105.03 Million ≈ $1.14 Million	0.163x	+120.74%
2008-03-31	Rs513.18 Million ≈ $5.55 Million	Rs-403.48 Million ≈ $-4.36 Million	-0.786x	-189.85%
2007-03-31	Rs135.84 Million ≈ $1.47 Million	Rs118.87 Million ≈ $1.29 Million	0.875x	+22.51%
2006-03-31	Rs116.74 Million ≈ $1.26 Million	Rs83.39 Million ≈ $901.79K	0.714x	--

About Kilitch Drugs (India) Limited

NSE:KILITCH India Drug Manufacturers - Specialty & Generic

Market Cap

$58.23 Million

Rs5.38 Billion INR

Market Cap Rank

#21298 Global

#1163 in India

Share Price

Rs154.02

Change (1 day)

-0.06%

52-Week Range

Rs124.45 - Rs487.85

All Time High

Rs487.85